Altria Group (MO) Consumer Analyst Group of New York Conference (CAGNY) 2026 summary
Event summary combining transcript, slides, and related documents.
Consumer Analyst Group of New York Conference (CAGNY) 2026 summary
18 Feb, 2026Leadership transition and strategic vision
CEO Billy Gifford is retiring in May, with Sal Mancuso set to take over leadership.
The company is focused on transitioning to a smoke-free future and expanding beyond nicotine and the U.S. market.
Emphasis on responsible harm reduction and capturing opportunities in evolving nicotine categories.
Enhanced capabilities and strategy enablers are being developed to support execution and flexibility.
Evolving nicotine market and consumer trends
U.S. nicotine market is shifting rapidly toward smoke-free products, with a 20% decline in combustibles and a 2% CAGR in total nicotine volume from 2020 to 2025.
Nearly half of adult smokers are interested in smoke-free alternatives, and over 4 million have transitioned since 2020.
Three main consumer groups—Traditionalists, Transitioners, and Variety Seekers—are shaping category dynamics and product innovation.
Consumer insights and portfolio strategy
Smoke-free adoption is rising, with over half of U.S. nicotine consumers now using smoke-free products.
Oral tobacco, especially nicotine pouches, is a key growth driver, with volumes up over 40% last year.
Oral tobacco industry volume is growing, with nicotine pouch consumers more than doubling from 2023 to 2025.
The oral portfolio is tailored to different consumer groups, offering a range of flavors and strengths.
Helix's on! PLUS pouches are gaining share, with 95% of surveyed consumers likely to repurchase.
Latest events from Altria Group
- 2025 adjusted EPS up 4.4% to $5.42, up to $10.2B returned, 2026 EPS guided at $5.56–$5.72.MO
Q4 20253 Feb 2026 - Net earnings up 51.9% to $5.93B on IQOS gain; NJOY and on! offset smokeable declines.MO
Q2 20242 Feb 2026 - Q3 adjusted EPS up 7.8%, 2024 guidance reaffirmed, and $600M cost-saving plan launched.MO
Q3 202417 Jan 2026 - 2024 saw robust EPS growth and cash returns, but illicit e-vapor clouds smoke-free outlook.MO
Q4 20249 Jan 2026 - Driving smoke-free innovation, global expansion, and strong returns amid regulatory challenges.MO
Consumer Analyst Group of New York Conference 20258 Jan 2026 - Q1 2025 adjusted EPS up 6% as e-vapor impairment and illicit market pressures persist.MO
Q1 202521 Dec 2025 - Annual meeting to vote on directors, auditor, compensation, and new incentive plans.MO
Proxy Filing1 Dec 2025 - Shareholders to vote virtually on directors, compensation, auditor, and incentive plans.MO
Proxy Filing1 Dec 2025 - All proposals passed with strong support as the company advances its smoke-free vision.MO
AGM 202519 Nov 2025